Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation

Similar documents
Supporting Information. Electrochemiluminescence for Electric-Driven Antibacterial. Therapeutics

Pulmonary Vein Stenosis After Radiofrequency Ablation of Atrial Fibrillation

Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey,

Optimization of Processing Parameters of Stabilizers After Enzymes Hydrolysis for Cloudy Ginkgo Juice

Accepted Manuscript. Hemorrhagic cystitis associated with gefitinib treatment: a case report. Peng Zhang, Jinjing Tu, Tieding Chen, Rubing Li

Chapter 5 Trimalleolar Ankle Fracture: Posterior Plate for Posterior Malleolus Fractures

ACCEPTED ARTICLE PREVIEW. Accepted manuscript

Fetal Response to Intramuscular Epinephrine for Anaphylaxis during Maternal Penicillin Desensitization for Secondary Syphilis

Accepted Manuscript. Robotics in Orthopedics: A Brave New World. Brian S. Parsley, MD, Associate Professor

Thinking & Reasoning Publication details, including instructions for authors and subscription information:

Mastering the Initial Dissection and Cannulation: Making Ablation Easy and Safe

Comparison of Carotid Artery Stenting and Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Stenosis: A Single Center Study

Effects of idebenone on electroencephalograms of patients with cerebrovascular disorders

Accepted Manuscript. Red yeast rice preparations: are they suitable substitutions for statins?

uncorrected proof version

Indacaterol, a once-daily beta 2 -agonist, versus twice-daily beta-agonists or placebo for chronic obstructive pulmonary disease (Protocol)

SOME PRACTICAL IMPROVEMENTS IN THE CONTINUAL REASSESSMENT METHOD FOR PHASE I STUDIES

Journal of Chromatography A 819 (1998)

Computerized Quantitative Coronary Angiography Applied to Percutaneous Transluminal Coronary Angioplasty: Advantages and Limitations

Synthetic Tannins Structure by MALDI-TOF Mass Spectroscopy

The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

Characterization of a prototype MR-compatible Delta4 QA-system in a 1.5 tesla MR-linac

The role of air plethysmography in the diagnosis of chronic venous insufficiency

Accepted Manuscript. Dural arteriovenous fistula between the inferolateral trunk and cavernous sinus draining to the ophthalmic vein: a case report

Colchicine for prevention and treatment of cardiac diseases: A meta-analysis

How might treatment of ALK-positive non-small cell lung cancer change in the near future?

EGC Diagnosis of Paroxysmal Supraventricular Tachycardias in Patients without Preexcitation

Over the past 5 years, the technique of catheter ablation of

Effects of regular exercise on asthma control in young adults

NON-NARCOTIC ORALLY EFFECTIVE, CENTRALLY ACTING ANALGESIC FROM AN AYURVEDIC DRUG

Pharmacokinetics of a Novel Orodispersible Tablet of Sildenafil in Healthy Subjects

How Advertising Slogans

Electrical isolation of the pulmonary veins (PVs) to treat

Parallel Stent Graft Techniques to Facilitate Endovascular Repair in the Aortic Arch

Transesophageal echocardiographic follow-up of pulmonary veins in patients undergoing ostial radiofrequency catheter ablation for atrial fibrillation

ORIGINAL ARTICLE ABSTRACT SUMMARY AT A GLANCE INTRODUCTION

Atrial ectopic beats within the pulmonary veins (PVs) are

Hard-tissue alterations following immediate implant placement in extraction sites

RAVEN'S COLORED PROGRESSIVE MATRICES AND INTELLECTUAL IMPAIRMENT IN PATIENTS WITH FOCAL BRAIN DAMAGE

Title: Clinical and histopathological features of immunoglobulin G4-associated autoimmune hepatitis in children

Validation of ATS clinical practice guideline cut-points for FeNO in asthma

Divergent Thinking and Evaluation Skills: Do They Always Go Together?

Effects of Angle of Approach on Cursor Movement with a Mouse: Consideration of Fitts' Law

THE RATIONALITY/EMOTIONAL DEFENSIVENESS SCALE- I. INTERNAL STRUCTURE AND STABILITY

HYDRONEPHROSIS DUE TO THE INFERIOR POLAR ARTERY :

Energy Metabolism in Oreochromis niloticus

A. Alonso-Burgos a, *, E. García-Tutor b, G. Bastarrika a, D. Cano a, A. Martínez-Cuesta a, L.J. Pina a

Author s Accepted Manuscript

Evidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins

Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening

Clinical investigation of chronic subdural hematoma with impending brain herniation on arrival

Incidence and predictors of synchronous liver metastases in patients with gastrointestinal stromal tumors (GISTs)

Marlowe Crowne Social Desirability Scale and Short Form C: Forensic Norms

Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis

ABSTRACT. questions in the version of NorAQ administered to men (m-noraq) against the interview model.

Nebulized Magnesium for Moderate and Severe Pediatric Asthma: A Randomized Trial

Contrasting timing of virological relapse after discontinuation of. tenofovir or entecavir in hepatitis B e antigen-negative patients.

Lung cancer is one of the major tumors that causes human

The Use of Transdermal Buprenorphine to Relieve Radiotherapy-Related Pain in Head and Neck Cancer Patients

164 J.A.H. an Laarho en et al. / International Journal of Pharmaceutics 232 (2002) An example of a sustained release system is a contraceptive

Splenomegaly and Hemolytic Anemia Induced in Rats by Methylcellulose - An electron microscopic study '

SYSTEMATIC REVIEW PROTOCOL

Cost-Effectiveness of Adding Rh-Endostatin to First-Line Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer in China

Low- vs. high-pressure suction drainage after total knee arthroplasty: a double-blind randomized controlled trial

Ovarian cancer is the most lethal gynecologic malignancy

Natural Course of Peripartum Cardiomyopathy

Introduction. urinary erythropoietin, and the two are indistinguishable

Effect of health Baduanjin Qigong for mild to moderate Parkinson s disease

A Diabetes Mobile App With In-App Coaching From a Certified Diabetes Educator Reduces A1C for Individuals With Type 2 Diabetes

Journal of Chromatography B, 857 (2007)

Use of Digoxin for Heart Failure and Atrial Fibrillation in Elderly Patients

Pulley lesions in rotator cuff tears: prevalence, etiology, and concomitant pathologies

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?

Lisfranc Arthrodesis for Chronic Pain: A Cannulated Screw Technique

Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes*

A Motivational Intervention to Reduce Cigarette

Address: Department of General Surgery, Royal Bolton Hospital, Bolton, UK. ; tel:

Efficacy, safety and impact on β

Functional Outcome of Unstable Distal Radius Fractures: ORIF With a Volar Fixed-Angle Tine Plate Versus External Fixation

A LABORATORY TASK FOR INDUCTION OF MOOD STATES*

LONG-TERM RESULTS OF A PHASE III TRIAL COMPARING ONCE-DAILY RADIOTHERAPY WITH TWICE-DAILY RADIOTHERAPY IN LIMITED- STAGE SMALL-CELL LUNG CANCER


Antiproliferative, antimigratory, and anticlonogenic effects of Hedyotis diffusa, Panax ginseng, and their combination on colorectal cancer cell lines

Combining ECMO with IABP for the Treatment of Critically Ill Adult Heart Failure Patients

PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE. PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

Development and psychometric evaluation of the Thirst Distress Scale for patients with heart failure

Catheter Ablation of Atrial Fibrillation

Serum mir-182 and mir-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma

Congenital absence of teeth is a common dental

Epithelial Barrier Defects in HT-29/B6 Colonic Cell Monolayers Induced by Tumor Necrosis Factor α

Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH

Yang S-S, Gao Y, Wang D-Y, Xia B-R, Liu Y-D, Qin Y, Ning X-M, Li G-Y, Hao L-X, Xiao M & Zhang Y-Y (2016) Histopathology. DOI: /his.

Hepatitis B virus (HBV) infection is a global health

Electrical Acupoint Stimulation Changes Body Composition and the Meridian Systems in Postmenopausal Women with Obesity

Memory-based attentional capture by colour and shape contents in visual working memory

Case Report Asymptomatic Pulmonary Vein Stenosis: Hemodynamic Adaptation and Successful Ablation

Effects of Mattress Material on Body Pressure Profiles in Different Sleeping Postures

Treatment of Class III Malocclusions Using Miniplate and Mini-Implant Anchorage

Training for Lung Ultrasound Score Measurement in Critically Ill Patients

Transcription:

Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation E.B. SAAD Introduction Catheter ablation around the pulmonary veins (PVs) has become the treatment of choice for symptomatic patients with atrial fibrillation (AF) who do not respond to pharmacological therapy [1 6]. Over the past few years, a variety of strategies have been developed to achieve cure of AF [7 16]. PV stenosis is a known potential complication of radiofrequency ablation (RF) around the PVs [17 24] and its recognition is important to avoid unnecessary workup and to initiate appropriate treatment. Incidence and Clinical Manifestations The incidence of PV stenosis following AF ablation has been variably reported, ranging from 0% to 42% depending on the ablative technique used and the method of assessment [7, 10, 20, 25, 26]. The latter number probably represents and overestimation since transoesophageal echocardiography (TEE) instead of an anatomical imaging modality was used to establish the diagnosis. Several factors contribute to an increased risk of developing PV stenosis, such as RF delivery inside the PVs, increasing power and temperature settings, and a learning curve effect [24, 27]. Recent reports have shown a trend towards a decreasing incidence of PV stenosis mainly due to limiting RF delivery at or outside the orifice of the veins, power titration based on monitoring of tissue effects of RF (as with microbubble formation on intrac- Section of Cardiac Arrhythmias and Pacing, Center for Atrial Fibrillation, Hospital Pró- Cardíaco, Botafogo, Rio de Janeiro, Brazil

242 E.B. Saad ardiac echocardiography) and increasing operator experience [10, 27]. In centres with a high volume of AF procedures, PV stenosis is becoming a disease in extinction. However, with the widespread application of AF ablation in the electrophysiologic community more procedures are being performed by less experienced operators, increasing the chances that the incidence of PV stenosis will actually increase. In fact, a recently presented review of the European experience with AF ablation detected up to 20% of patients developing PV stenosis in centres performing less than 50 procedures. Physicians in general should thus be ready to work up patients with symptoms developing after an ablation procedure. However, PV stenosis after RF ablation is frequently asymptomatic, especially when a mild or moderate degree of stenosis is present or a single vein is involved [21, 22]. Most important is the fact that, when present, symptoms appear to be largely respiratory in origin [23], usually developing between the first and fourth month after the index procedure. The spectrum of symptoms range from persistent cough and pleuritic chest pain to more dramatic presentations, such as haemoptysis and severe exertional dyspnoea (Table 1). The severity of symptoms may be related not only to the degree of stenosis but also to the number of PVs with stenosis, with almost all patients with 2 PVs with severe stenosis being symptomatic (Fig. 1). However, given the non-specific nature of these symptoms and the frequent association with radiological evidence of lung consolidation, it is not surprising that many patients are initially treated for other common conditions, such as pneumonia (Fig. 2) and Table 1. Clinical presentation and CT findings in patients with severe pulmonary vein (PV) stenosis Patients (n = 21) n (%) Clinical presentation Cough 8 (38.1) Dyspnoea 11 (52.4) Pleuritic chest pain 6 (28.6) Haemoptysis 5 (23.8) Asymptomatic 8 (38.1) Spiral CT: > 70% PV stenosis (n = occluded PVs) LSPV 14 (6) LIPV 15 (7) RSPV 4 (1) RIPV 3 (1) LSPV Left superior PV, LIPV left inferior PV, RSPV right superior PV, RIPV right inferior PV

Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation 243 Fig. 1. Correlation between the presence of respiratory symptoms and number of pulmonary veins (PVs) with severe stenosis. While less than 1/3 of patients with single-vessel stenosis have symptoms, the majority of patients with more than one PV involved are symptomatic. Pulmonary arterial hypertension is rare and can be documented only in patients with multi-vessel involvement Fig. 2. CT scan of a patient with pulmonary consolidation initially attributed to pneumonia. There is a clear lung infiltrate in the periphery of the left lung (arrows). The patient did not respond to several antimicrobial regimens and was subsequently diagnosed with PV stenosis pulmonary embolism, before the correct diagnosis is made [21, 23, 28]. Indeed, we published a series of 18 patients developing severe PV stenosis after AF ablation who were followed by their primary-care physicians, and in

244 E.B. Saad all patients PV stenosis was not considered in the differential diagnosis [21]. Misdiagnoses lead to improper diagnostic and therapeutic procedures, such as prolonged antibiotic treatment (5 patients), treatment for possible asthmatic syndrome and bronchitis (3 patients), placement of a vena cava filter (1 patient), and lung resection surgery (1 patient). Therefore, if a high degree of alertness and awareness is not present, this diagnosis can remain unknown. Diagnostic Methods and Therapeutic Interventions Strong suspicion is required to promptly diagnose PV stenosis, not only because it can mimic more prevalent respiratory and cardiovascular syndromes but also because diagnostic tests can be misleading, as we and others previously described [21 23, 28]. A number of imaging modalities have been used in the evaluation of PV stenosis. CT scanning is probably the most helpful since it can reliably identify the location and extension of the lesions (Fig. 3), while providing assessment of concomitant lung (e.g. consolidation or haemorrhage), mediastinal, and hilar (e.g. enlarged nodes) abnormalities Fig. 3. Spiral CT scan at the level of the inferior PVs demonstrating a severe narrowing (arrow) of the proximal portion of the left inferior PV (LIPV). This location probably indicates that radiofrequency (RF) lesions were in fact placed inside the vein. RIPV Right inferior PV, LA left atrium

Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation 245 (Fig. 2). The only caveat is that some vessels that appear totally occluded on CT scanning are in fact patent when evaluated by PV angiography [29], the gold-standard diagnostic modality. Magnetic resonance angiography can also be performed with comparable results and has the advantage of avoiding iodine contrast injection [30 33]. Echocardiography has also been used to detect and predict the development of PV stenosis. TEE can provide accurate views of the superior PVs, and increased flow velocity on Doppler has been used as a surrogate for decreased luminal diameter. However, experience with intracardiac echocardiography (ICE) has demonstrated that even vessels with markedly increased flow velocities may not show significant stenosis when evaluated by CT or angiography [34]. As such, we believe that significant overestimation of the degree of stenosis may occur with an echo-based assessment. Ventilation/perfusion (V/Q) scanning is a simple and accurate method to detect and evaluate the haemodynamic consequences of PV stenosis, the most common finding being a segmental perfusion abnormality in the presence of normal ventilation (similar to findings seen in pulmonary arterial embolism). In our experience, perfusion defects occur mainly when the degree of PV luminal narrowing is 70% [22], indicating that mild and moderate degrees of narrowing have minimal, if any, consequence on the physiology of the pulmonary circulation. Severe PV stenosis, in contrast, is associated with significant reduction in the pulmonary flow, which is only partially reversible even after successful treatment with PV dilatation. In our series evaluating 18 patients with severe PV stenosis, average pulmonary flow to the left lung increased from 11.7 ± 10.2% to 22.3 ± 10.8% after PV intervention [21]. Percutaneous PV dilatation is currently the treatment of choice for patients with symptoms attributable to severe PV stenosis, and it is associated with significant improvement in pressure gradients, venous diameter, lung perfusion, and symptoms [23, 29]. In a recent study involving 19 patients undergoing interventional procedures in 30 PVs, functional classification improved dramatically from a mean NYHA score of 3.1 to 1.7, with most patients able to perform their usual activities with no or only minimal limitation [29]. Unfortunately, the short-term results are not maintained, with approximately 50% of patients developing restenosis and necessitating repeat interventions [23, 29]. PV stenting does not appear to provide better results than simple balloon dilatation, at least when bare-metal stents are used. Currently, there is no published experience regarding the use of drugcoated stents, but better results are expected based on their successful use in the coronary arteries and in saphenous vein grafts.

246 E.B. Saad Prognosis and Importance of Preventive Strategies Progression of PV stenosis beyond the third month after ablation is rare but can occur in up to 10% of patients [22], indicating the need to repeat imaging evaluation every 3 6 months or if symptoms develop or worsen. More commonly, the degree of narrowing remains stable or improves (up to 30% of patients), probably reflecting the inflammatory nature of PV pathology. Based on these data, we recommend routine imaging evaluation with either CT or MRI 3 months after the procedure, irrespective of the presence of symptoms. If no stenosis is detected, no further evaluation is needed unless compatible symptoms develop. In the presence of luminal narrowing, repeat evaluation is undertaken at 6 and 12 months. Development of pulmonary arterial hypertension appears to be extremely rare and occurs only in the presence of severe stenosis of several PVs (Fig. 1). Importantly, it is almost always associated with severe symptoms and appears to be reversible when PV dilatation is performed. Risk factors for the development of PV stenosis, although yet to be completely defined, include energy delivery inside the veins [18, 24, 32], vein size, and use of excessive power during RF applications [22, 24]. As such, reliable and precise delineation of the PV left atrium (LA) junction appears to be important. Our initial experience with ostial isolation based on electroanatomical mapping to delineate the PVs proved to be disappointing, with isolation observed in only 31% of treated veins and with severe stenosis developing in 15.5% of patients, comparable to the 20% severe stenosis rate obtained when we performed distal PV isolation based on a circular catheter in a selected group of patients. Once it became clear that we had to avoid lesions inside the veins, selective PV angiography was utilised to determine the ostia. This approach decreased the incidence of severe stenosis to about 3%. However, in our experience the use of ICE was associated with the most considerable decrease in the occurrence of stenosis. When used to guide ostial positioning of the circular catheter (Fig. 4), it reduced severe stenosis to 1.4%. It is likely that angiography in not always reliable for adequate ostial visualisation because of the streaming effect of the contrast in the vein and the frequent gradual funnelling of the PV junction into the left atrial cavity. Traditional methods for titration of energy delivery, such as tip temperature and impedance measures, may not be accurate [35]. This is especially true for left-side procedures, during which the use of excessive power may result in thromboembolic complications. Thus, the development of a reliable method to achieve more accurate energy delivery is needed and visualisation of microbubbles by ICE is a suitable option, being associated with a significantly reduced incidence of severe PV stenosis. Indeed, it is remarkable that

Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation 247 Fig. 4. Example of the use of intracardiac echocardiography (ICE) to guide ostial positioning of a circular mapping catheter in the right inferior PV (RIPV). The circular catheter is placed on the atrial side of the PV LA junction, allowing real-time monitoring and avoiding the need for PV angiography. LA Left atrium, RA right atrium none of our patients have developed severe stenosis since this strategy was introduced. The rationale for microbubble-guided power titration lies in the premise that adequate tissue heating cannot be predicted simply by monitoring impedance and temperature. Instead, the formation of scattered microbubbles is believed to reflect significant tissue overheating [10, 36 38]. When this occurs, energy deliver has to be interrupted. However, if this phenomenon cannot be controlled, tissue desiccation will result, creating the milieu for coagulum formation and PV stenosis. Other experienced groups also reported avoidance of PV stenosis just by performing circumferential ablation well outside the PVs [7, 12, 15, 39], usually up to 1 cm away from the PV LA junction, a strategy that does not necessarily aim for PV isolation [39, 40]. Conclusions Albeit almost an extinct complication in high-volume and experienced centres, PV stenosis most likely will continue to be a feared complication of AF ablative procedures, as they are more often performed in community set-

248 E.B. Saad tings by less-experienced operators. Severe PV stenosis is associated with a variety of respiratory symptoms that frequently mimic more common heart and lung diseases. A high degree of suspicion is necessary to avoid misleading diagnostic procedures and allow proper and prompt management of these patients. PV dilatation is the treatment of choice for symptomatic patients but is still associated with a frequent need for repeat interventions due to restenosis. It remains to be seen whether the use of drug-coated stents will provide long-lasting results. Emphasis should be placed on prevention and imaging modalities that help to accurately delineate the PV LA junction and guide power titration, both of which appear to provide the best means to avoid PV injury by RF energy. References 1. Haïssaguerre M, Jaïs P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659 666 2. Marrouche NF, Dresing T, Cole C et al (2002) Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol 40:464 474 3. Pappone C, Oreto G, Rosanio S et al (2001) Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104:2539 2544 4. Chen SA, Tai CT, Tsai CF et al (2000) Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats. J Cardiovasc Electrophysiol 11:218 227 5. Oral H, Knight BP, Tada H et al (2002) Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 105:1077 1081 6. Gerstenfeld EP, Guerra P, Sparks PB et al (2001) Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 12:900 908 7. Pappone C, Rosanio S, Oreto G et al (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 102:2619 2628 8. Natale A, Pisano E, Shewchik J et al (2000) First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 102:1879 1882 9. Jaïs P, Hocini M, Macle L et al (2002) Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 106:2479 2485 10. Marrouche NF, Martin DO, Wazni O et al (2003) Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 107(21):2710 2716 11. Kanagaratnam L, Tomassoni G, Schweikert R et al (2001) Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional

Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation 249 nonfluoroscopic mapping system: long-term follow-up. Pacing Clin Electrophysiol 24:1774 1779 12. Oral H, Scharf C, Chugh A et al (2003) Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108:2355 2360 13. Nademanee K, McKenzie J, Kosar E et al (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044 2053 14. Pappone C, Santinelli V, Manguso F et al (2004) Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109:327 334 15. Ouyang F, Bansch D, Ernst S et al (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090 2096 16. Cappato R, Calkins H, Chen SA et al (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100 1105 17. Scanavacca MI, Kajita LJ, Vieira M et al (2000) Pulmonary vein stenosis complicating catheter ablation of focal atrial fibrillation. J Cardiovasc Electrophysiol 11:677 681 18. Yu WC, Hsu TL, Tai CT et al (2001) Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 12:887 892 19. Robbins IM, Colvin EV, Doyle TP et al (1998) Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 98:1769 1775 20. Arentz T, Jander N, von Rosenthal J et al (2003) Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J 24:963 969 21. Saad EB, Marrouche NF, Saad CP et al (2003) Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med 138:634 638 22. Saad EB, Rossillo A, Saad CP et al (2003) Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation 108:3102 3107 23. Packer DL, Keelan P, Munger TM et al (2005) Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation 111:546 554 24. Purerfellner H, Cihal R, Aichinger J et al (2003) Pulmonary vein stenosis by ostial irrigated-tip ablation: incidence, time course, and prediction. J Cardiovasc Electrophysiol 14:158 164 25. Chen SA, Hsieh MH, Tai CT et al (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879 1886 26. Haïssaguerre M, Jaïs P, Shah DC et al (2000) Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101:1409 1417 27. Knight BP, Oral H, Chugh A et al (2003) Effects of operator experience on the outcome and duration of pulmonary vein isolation procedures for atrial fibrillation. Am J Cardiol 91:673 677

250 E.B. Saad 28. Ernst S, Ouyang F, Goya M et al (2003) Total pulmonary vein occlusion as a consequence of catheter ablation for atrial fibrillation mimicking primary lung disease. J Cardiovasc Electrophysiol 14:366 370 29. Qureshi AM, Prieto LR, Latson LA et al (2003) Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation. Circulation 108:1336 1342 30. Carriero A, Marano R, Fossaceca R et al (1998) Pulmonary veins: magnetic resonance angiography anatomy. Magma 6:2 6 31. Yang M, Akbari H, Reddy GP et al (2001) Identification of pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation using MRI. J Comput Assist Tomogr 25:34 35 32. Kato R, Lickfett L, Meininger G et al (2003) Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation 107:2004 2010 33. Dill T, Neumann T, Ekinci O et al (2003) Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging. Circulation 107:845 850 34. Saad EB, Cole CR, Marrouche NF et al (2002) Use of intracardiac echocardiography for prediction of chronic pulmonary vein stenosis after ablation of atrial fibrillation. J Cardiovasc Electrophysiol 13:986 989 35. Farah A, Khan F, Machado C (2000) Thrombus formation at the site of radiofrequency catheter ablation. Pacing Clin Electrophysiol 23:538 540 36. Kalman JM, Fitzpatrick AP, Olgin JE et al (1997) Biophysical characteristics of radiofrequency lesion formation in vivo: dynamics of catheter tip-tissue contact evaluated by intracardiac echocardiography. Am Heart J 133:8 18 37. Bunch TJ, Bruce GK, Johnson SB et al (2004) Analysis of catheter-tip (8-mm) and actual tissue temperatures achieved during radiofrequency ablation at the orifice of the pulmonary vein. Circulation 110:2988 2995 38. Wood MA, Shaffer KM, Ellenbogen AL et al (2005) Microbubbles during radiofrequency catheter ablation: Composition and formation. Heart Rhythm 2:397 403 39. Cappato R, Negroni S, Pecora D et al (2003) Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation 108:1599 1604 40. Hocini M, Sanders P, Jaïs P et al (2005) Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins. Eur Heart J 26:696 704

本文献由 学霸图书馆 - 文献云下载 收集自网络, 仅供学习交流使用 学霸图书馆 (www.xuebalib.com) 是一个 整合众多图书馆数据库资源, 提供一站式文献检索和下载服务 的 24 小时在线不限 IP 图书馆 图书馆致力于便利 促进学习与科研, 提供最强文献下载服务 图书馆导航 : 图书馆首页文献云下载图书馆入口外文数据库大全疑难文献辅助工具